Pharmacokinetics of Three PDE5Is Completed Phase 1 Trials for Sildenafil (DB00203)

IndicationStatusPhase
DBCOND0041853 (Pharmacokinetics of Three PDE5Is)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00767598The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male SubjectsBasic Science